# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-21-042768
Filing Date
2021-03-29
Accepted
2021-03-29 07:29:34
Documents
31
Period of Report
2021-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2111026d1_8k.htm | 8-K | 45189
2 | EXHIBIT 2.1 | tm2111026d1_ex2-1.htm | EX-2.1 | 674922
3 | EXHIBIT 10.1 | tm2111026d1_ex10-1.htm | EX-10.1 | 55996
4 | EXHIBIT 10.2 | tm2111026d1_ex10-2.htm | EX-10.2 | 57891
5 | EXHIBIT 10.3 | tm2111026d1_ex10-3.htm | EX-10.3 | 32015
6 | EXHIBIT 99.1 | tm2111026d1_ex99-1.htm | EX-99.1 | 25513
7 | EXHIBIT 99.2 | tm2111026d1_ex99-2.htm | EX-99.2 | 31224
8 | GRAPHIC | tm2111026d1_ex99-1img001.jpg | GRAPHIC | 18105
9 | GRAPHIC | tm2111026d1_ex99-2img001.jpg | GRAPHIC | 49443
10 | GRAPHIC | tm2111026d1_ex99-2img002.jpg | GRAPHIC | 215705
11 | GRAPHIC | tm2111026d1_ex99-2img003.jpg | GRAPHIC | 88133
12 | GRAPHIC | tm2111026d1_ex99-2img004.jpg | GRAPHIC | 94058
13 | GRAPHIC | tm2111026d1_ex99-2img005.jpg | GRAPHIC | 109568
14 | GRAPHIC | tm2111026d1_ex99-2img006.jpg | GRAPHIC | 94163
15 | GRAPHIC | tm2111026d1_ex99-2img007.jpg | GRAPHIC | 86560
16 | GRAPHIC | tm2111026d1_ex99-2img008.jpg | GRAPHIC | 33265
17 | GRAPHIC | tm2111026d1_ex99-2img009.jpg | GRAPHIC | 98568
18 | GRAPHIC | tm2111026d1_ex99-2img010.jpg | GRAPHIC | 88522
19 | GRAPHIC | tm2111026d1_ex99-2img011.jpg | GRAPHIC | 104500
20 | GRAPHIC | tm2111026d1_ex99-2img012.jpg | GRAPHIC | 126487
21 | GRAPHIC | tm2111026d1_ex99-2img013.jpg | GRAPHIC | 109722
22 | GRAPHIC | tm2111026d1_ex99-2img014.jpg | GRAPHIC | 32935
23 | GRAPHIC | tm2111026d1_ex99-2img015.jpg | GRAPHIC | 81274
24 | GRAPHIC | tm2111026d1_ex99-2img016.jpg | GRAPHIC | 90515
25 | GRAPHIC | tm2111026d1_ex99-2img017.jpg | GRAPHIC | 101344
26 | GRAPHIC | tm2111026d1_ex99-2img018.jpg | GRAPHIC | 115866
27 | GRAPHIC | tm2111026d1_ex99-2img019.jpg | GRAPHIC | 125754
28 | GRAPHIC | tm2111026d1_ex99-2img020.jpg | GRAPHIC | 31708
29 | GRAPHIC | tm2111026d1_ex99-2img021.jpg | GRAPHIC | 110358
30 | GRAPHIC | tm2111026d1_ex99-2img022.jpg | GRAPHIC | 111989
31 | GRAPHIC | tm2111026d1_ex99-2img023.jpg | GRAPHIC | 38099
| Complete submission text file | 0001104659-21-042768.txt |  | 3895072

Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 21779451
SIC: 2834 Pharmaceutical Preparations